Benign liver tumours: understanding molecular physiology to adapt clinical management
- 14 July 2022
- journal article
- review article
- Published by Springer Nature in Nature Reviews Gastroenterology & Hepatology
- Vol. 19 (11) , 703-716
Abstract
Improvements in understanding the pathophysiology of the different benign liver nodules have refined their nosological classification. New criteria have been identified using imaging, histology and molecular analyses for a precise diagnosis of these tumours. Improvement in the classification of liver tumours provides a more accurate prediction of disease progression and has modified patient management. Haemangioma and focal nodular hyperplasia, the most common benign liver tumours that develop in the absence of chronic liver disease, are usually easy to diagnose on imaging and do not require specific treatment. However, hepatocellular adenomas and cirrhotic macronodules can be difficult to discriminate from hepatocellular carcinoma. The molecular subtyping of hepatocellular adenomas in five major subgroups defined by HNF1A inactivation, β-catenin mutation in exon 3 or exon 7/8, and activation of inflammatory or Hedgehog pathways helps to identify the tumours at risk of malignant transformation or bleeding. New clinical, biological and molecular tools have gradually been included in diagnostic and treatment algorithms to classify benign liver tumours and improve patient management. This Review aims to explain the main pathogenic mechanisms of benign liver tumours and how this knowledge could influence clinical practice.Keywords
This publication has 119 references indexed in Scilit:
- Immunohistochemical Markers on Needle Biopsies Are Helpful for the Diagnosis of Focal Nodular Hyperplasia and Hepatocellular Adenoma SubtypesAmerican Journal of Surgical Pathology, 2012
- The value of immunophenotyping hepatocellular adenomas: consecutive resections at one UK centreHistopathology, 2012
- Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomasJournal of Experimental Medicine, 2011
- Hepatocellular adenomas: Accuracy of magnetic resonance imaging and liver biopsy in subtype classificationHepatology, 2011
- Hepatocellular adenoma management and phenotypic classificationHepatology, 2009
- Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia # †Hepatology, 2009
- Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumoursNature, 2008
- Hepatocellular adenomas: Magnetic resonance imaging features as a function of molecular pathological classificationHepatology, 2008
- Inflammatory syndrome with liver adenomatosis: the beneficial effects of surgical managementGut, 2007
- Oral contraceptive intake in women with focal nodular hyperplasia of the liverThe Lancet, 1998